Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Chemoprevention of Skin Cancer Biomarkers
NCT02636569Phase 2Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Oct 2017
- Primary completion
- Dec 2025
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of diclofenac in non-melanoma skin cancer (NMSC), actinic keratosis (AK), sponsored by University of Alabama at Birmingham. Started Oct 2017; status: completed.
02
Drugs
diclofenac
03
Conditions
non-melanoma skin cancer (NMSC)actinic keratosis (AK)
Beyond the preview
Go deeper on NCT02636569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02636569.